Abstract
Insulin therapy has proven benefits in Type 2 diabetes patients when combination therapy has failed. However, there is some reluctance by both patients and healthcare professionals to initiate insulin therapy. This reluctance has been termed ‘psychological insulin resistance’. Barriers to the initiation of insulin therapy include patients‘ fear of disease progression and needle anxiety; mutual concerns about hypoglycaemia and weight gain; and health professionals' use of insulin as a threat to encourage compliance with earlier therapies. It is essential that these obstacles are identified and investigated as a means of overcoming these impediments to recommended levels of glycaemic control, an initiative being pursued by the DAWN study. Where concerns are tangible, such as fear of hypoglycaemia, therapeutic solutions can be pursued. Overcoming psychological barriers relies more on innovative management techniques. Improving insulin delivery to meet these needs, coupled with enhanced healthcare services, can address psychological insulin resistance and contribute to the maintenance of good metabolic control.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korytkowski, M. When oral agents fail: practical barriers to starting insulin. Int J Obes 26 (Suppl 3), S18–S24 (2002). https://doi.org/10.1038/sj.ijo.0802173
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802173
Keywords
This article is cited by
-
A qualitative study of the experiences of insulin use by older people with type 2 diabetes mellitus
BMC Primary Care (2024)
-
Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study
Diabetes Therapy (2021)
-
Beliefs of Caribbean type 2 diabetes patients towards insulin therapy and prescription
International Journal of Diabetes in Developing Countries (2020)
-
Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study
Diabetes Therapy (2020)
-
Experiences of Attending Group Education to Support Insulin Initiation in Type 2 Diabetes: A Qualitative Study
Diabetes Therapy (2020)